Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Imcheck Therapeutics
Sponsor

Imcheck Therapeutics

France 9e Arrondissement, 31 Chemin Joseph Aiguier, 13009 Marseille, France

About the sponsor

Imcheck Therapeutics focuses on advanced-stage and relapsed/refractory cancer, with clinical interest in treatment-resistant disease across multiple solid tumor settings.

  • Metastatic colorectal cancer
  • Metastatic ovarian cancer
  • Metastatic pancreatic ductal adenocarcinoma

The sponsor’s oncology portfolio includes tumors with limited treatment options, reflecting a strong emphasis on difficult-to-treat metastatic disease.

About Specializations

Imcheck Therapeutics runs clinical trials in conditions such as Haematological malignancy, Neoplasm malignant, Colorectal cancer metastatic, Pancreatic carcinoma metastatic, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Haematological malignancy+1

Not recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ict01
  • Sponsor:Imcheck Therapeutics

Colorectal cancer metastatic+4

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Aldesleukin
  • Sponsor:Imcheck Therapeutics

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.